New York State Common Retirement Fund Taysha Gene Therapies, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,100 shares of TSHA stock, worth $37,136. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,100
Previous 64,800
67.44%
Holding current value
$37,136
Previous $145,000
71.03%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TSHA
# of Institutions
117Shares Held
136MCall Options Held
25.9KPut Options Held
24K-
Avoro Capital Advisors LLC New York, NY18.7MShares$32.8 Million0.56% of portfolio
-
Rtw Investments, LP New York, NY14.9MShares$26.3 Million0.48% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$20.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$19.1 Million0.3% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$15.8 Million1.87% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $85.1M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...